Molecular Signaling in CSCs

CSCs rely on several critical signaling pathways that regulate their survival, proliferation, and ability to resist therapies. This track focuses on understanding key molecular pathways like Wnt/β-catenin, Hedgehog, Notch, and TGF-β, which govern CSC behavior. The dysregulation of these pathways often results in uncontrolled cell growth, maintenance of stemness, and enhanced survival capabilities of CSCs. Researchers aim to identify how mutations or aberrant signaling contribute to cancer initiation and metastasis. Targeting these signaling pathways holds great promise for therapies that selectively eliminate CSCs without harming normal stem cells. By understanding the molecular underpinnings of CSC regulation, novel inhibitors and therapeutic strategies can be developed to block CSC-driven tumorigenesis and overcome treatment resistance, leading to better clinical outcomes.

    Related Conference of Molecular Signaling in CSCs

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Molecular Signaling in CSCs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in